Global Cardiology Summit 2026 · 2026-06-15 · Cardiology

Clinical Features and Early Detection of Cognitive Impairment in Patients with Chronic Cerebral Ischemia

Sodiqova Ozoda¹, Elboboyeva Moxinur², Berdimurodova Mavsuma³
1st year clinical residency students of the Department of Neurology of Samarkand State Medical University¹'²'³,

View on AAMS · All conferences

Abstract

Chronic cerebral ischemia is a progressive neurological condition associated with long-term insufficiency of cerebral blood circulation and structural brain changes. The disease frequently leads to cognitive dysfunction, decreased quality of life, and impairment of daily activities. Early identification of cognitive decline in patients with chronic cerebral ischemia is essential for timely therapeutic intervention and prevention of disease progression. Modern clinical and neuropsychological assessment methods have improved diagnostic capabilities and facilitated earlier detection of neurological deficits. This study aimed to evaluate the clinical manifestations and early diagnostic approaches for cognitive impairment in patients with chronic cerebral ischemia. The results demonstrated that comprehensive neurological assessment significantly improves early recognition and management of cognitive dysfunction.

Keywords: chronic cerebral ischemia, cognitive impairment, neurology, cerebral circulation, neuropsychological assessment, early diagnosis, neurological disorders.

Chronic cerebral ischemia is considered one of the most common neurological disorders among adult and elderly populations and is frequently associated with vascular risk factors including hypertension, diabetes mellitus, atherosclerosis, and cardiovascular diseases. Persistent reduction in cerebral blood flow may result in gradual neuronal damage and impairment of cognitive function. Early stages often manifest with subtle symptoms including memory disturbances, decreased attention, sleep disorders, and emotional instability. Delayed recognition may lead to progressive neurological deficits and reduced functional independence. Therefore, early identification and intervention remain important objectives in neurological practice.

The aim of this study was to assess clinical manifestations and evaluate methods for early detection of cognitive impairment in patients with chronic cerebral ischemia.

The study included 85 patients diagnosed with chronic cerebral ischemia aged between 45 and 75 years. Clinical neurological examination and neuropsychological evaluation were performed using standardized cognitive assessment scales. Additional investigations included magnetic resonance imaging, Doppler ultrasonography of cerebral vessels, laboratory tests, and assessment of vascular risk factors. Statistical analysis was used to determine relationships between clinical findings and severity of cognitive dysfunction.

The study revealed that memory impairment, decreased concentration, headaches, dizziness, and emotional disturbances represented the most common symptoms among patients with chronic cerebral ischemia. Neuropsychological evaluation demonstrated varying degrees of cognitive dysfunction, predominantly affecting attention and short-term memory. Imaging studies showed structural changes associated with chronic vascular insufficiency. Early diagnosis through comprehensive clinical assessment facilitated timely initiation of treatment and contributed to stabilization of neurological status and improved quality of life.

Early recognition of cognitive impairment in patients with chronic cerebral ischemia plays a crucial role in preventing disease progression and reducing neurological disability. Combined neurological, neuropsychological, and imaging assessments improve diagnostic accuracy and allow timely therapeutic intervention. Comprehensive management strategies may contribute to better functional outcomes and preservation of cognitive abilities.

1. Gorelick P.B., Scuteri A., Black S.E., et al. Vascular contributions to cognitive impairment and dementia. Stroke. 2011;42(9):2672–2713.

2. Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80(4):844–866.

3. O'Brien J.T., Thomas A. Vascular dementia. Lancet. 2015;386(10004):1698–1706.

4. Kalaria R.N. Neuropathological diagnosis of vascular cognitive impairment. J Neurol Sci. 2016;299(1–2):3–6.

5. Hachinski V. Stroke and vascular cognitive impairment. Stroke. 2007;38(2):139–141.

6. Smith E.E. Clinical presentations and epidemiology of vascular dementia. Clin Sci. 2017;131(11):1059–1068.

7. Sachdev P.S. Vascular cognitive impairment. Int Psychogeriatr. 2014;26(1):1–8.

8. med1.uz – Educational resources on neurology and cerebrovascular disorders.

9. Pantoni L. Cerebral small vessel disease and cognitive impairment. Lancet Neurol. 2010;9(7):689–701.

10. Roman G.C., Sachdev P., Royall D.R., et al. Vascular cognitive disorder criteria. Alzheimers Dement. 2004;1(1):1–6.